Trial Profile
Effects of Ticagrelor and Intracoronary Morphine on Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Morphine
- Indications Myocardial infarction; Stroke; Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics
- 04 Jul 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
- 03 Jul 2013 Planned end date changed from 1 Dec 2015 to 31 Dec 2015 as reported by Korean Clinical Trials Register record.
- 03 Jul 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000757).